Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus

被引:0
作者
Krzysztof Domagalski [1 ]
Ma?gorzata Paw?owska
Agnieszka Zale?na
Ma?gorzata Pilarczyk
Pawe? Rajewski
Waldemar Halota [2 ]
Andrzej Tretyn [4 ]
机构
[1] Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University
[2] Provincial Infectious Diseases Hospital in Bydgoszcz  4. Department of Plant Physiology and Biotechnology, Nicolaus Copernicus University
[3] Department of Paediatric Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun
关键词
Chronic hepatitis B; IL28B; OAS; Singlenucleotide polymorphisms; IFN therapy; Children;
D O I
暂无
中图分类号
R725.1 [小儿传染病];
学科分类号
100202 ;
摘要
AIM To investigate the impact of IL28 B and OAS gene polymorphisms on interferon treatment responses in children with chronic hepatitis B.METHODS We enrolled 52 children(between the ages of 4 and 18) with hepatitis B e antigen-negative chronic hepatitis B(CHB), who were treated with pegylated interferon alfa for 48 wk. Single nucleotide polymorphisms in the OAS1(rs1131476), OAS2(rs1293747),OAS3(rs2072136), OASL(rs10849829) and IL28B(rs12979860, rs12980275 and rs8099917) genes were studied to examine their associations with responses to IFN treatment in paediatric patients. We adopted two criteria for the therapeutic response, achieving an hepatitis B virus(HBV) DNA level < 2000 IU/m L and normalization of ALT activity(< 40 IU/L). To perform the analyses, we compared the patients in terms of achieving a partial response(PR) and a complete response(CR) upon measurement at the 24-wk posttreatment follow-up. RESULTS The PR and CR rates were 80.8% and 42.3%, respectively. Factors such as age, gender and liver histology had no impact on the type of response(partial or complete). A statistically significant relationship between higher baseline HBV DNA and ALT activity levels and lower rates of PR and CR was shown(P < 0.05). The allele association analysis revealed that only the IL-28 B rs12979860(C vs T) and IL28 B rs12980275(A vs G) markers significantly affected the achievement of PR(P = 0.021, OR = 3.3, 95%CI: 1.2-9.2 and P = 0.014, OR = 3.7, 95%CI: 1.3-10.1, respectively). However, in the genotype analysis, only IL-28 B rs12980275 was significantly associated with PR(AA vs AG-GG, P = 0.014, OR = 10.9, 95%CI: 1.3-93.9). The association analysis for CR showed that the TT genotype of IL28 B rs12979860 was present only in the no-CR group(P = 0.033) and the AA genotype of OASL rs10849829 was significantly more frequent in the noCR group(P = 0.044, OR = 0.26, 95%CI: 0.07-0.88). The haplotype analysis revealed significant associations between PR and CR and OAS haplotype(P = 0.0002 and P = 0.001, respectively), but no association with IL28 B haplotype was observed.CONCLUSION IL28 B and OAS polymorphisms are associated with different clinical outcomes in CHB children treated with interferon.
引用
收藏
页码:9186 / 9195
页数:10
相关论文
共 50 条
  • [31] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Younossi, Zobair M.
    Birerdinc, Aybike
    Estep, Mike
    Stepanova, Maria
    Afendy, Arian
    Baranova, Ancha
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [32] Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
    Liapakis, AnnMarie
    Jesudian, Arun B.
    [J]. PHARMACOGENOMICS, 2012, 13 (12) : 1317 - 1319
  • [33] Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients
    Riva, E.
    Scagnolari, C.
    Monteleone, K.
    Selvaggi, C.
    Picardi, A.
    Mazzarelli, C.
    Pizzigallo, E.
    Vincenzi, B.
    Carducci, A.
    Antonaci, S.
    Giannelli, G.
    Antonelli, G.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2012, 19 (09) : 650 - 653
  • [34] The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
    Mach, Tomasz
    Ciesla, Andrzej
    Sanak, Marek
    Glowacki, Mikolaj
    Warunek, Wioleta
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 38 - 42
  • [35] Genetics of IL28B and HCV-response to infection and treatment
    Hayes, C. Nelson
    Imamura, Michio
    Aikata, Hiroshi
    Chayama, Kazuaki
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (07) : 406 - 417
  • [36] Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin
    Jablonowska, Elzieta
    Piekarska, Anna
    Koslinska-Berkan, Ewa
    Omulecka, Aleksandra
    Szymanska, Bozena
    Wojcik, Kamila
    [J]. ACTA BIOCHIMICA POLONICA, 2012, 59 (03) : 333 - 337
  • [37] HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
    Seto, Wai-Kay
    Wong, Danny Ka-Ho
    Kopaniszen, Malgorzata
    Proitsi, Petroula
    Sham, Pak-Chung
    Hung, Ivan Fan-Ngai
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1695 - 1703
  • [38] IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
    Ahlenstiel, Golo
    Booth, David R.
    George, Jacob
    [J]. JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) : 903 - 910
  • [39] IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice
    Golo Ahlenstiel
    David R. Booth
    Jacob George
    [J]. Journal of Gastroenterology, 2010, 45 : 903 - 910
  • [40] Comparison of four methods of genotyping IL28B polymorphisms in chronic hepatitis C patients
    Delvaux, Nathalia
    da Costa, Vanessa Duarte
    da Costa, Maristella Matos
    Lampe, Elisabeth
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2015, 220 : 1 - 4